Company profile for Core One Labs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Core One Labs is a biotech company focused on bringing psychedelic medicine to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. We bring patients psychedelic inspired medicines and experiential therapies that help them tap into the mind's own healing capabilities. We are new type of pharma company focused on overall patient health. Mental health and addiction is...
Core One Labs is a biotech company focused on bringing psychedelic medicine to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. We bring patients psychedelic inspired medicines and experiential therapies that help them tap into the mind's own healing capabilities. We are new type of pharma company focused on overall patient health. Mental health and addiction is a growing problem for people around the world and we are working on a novel solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
3123 - 595 Burrard Street, Vancouver, BC V7X 1J1
Telephone
Telephone
+1 (866) 347-5058
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accesswire.com/717290/Core-One-Labs-Signs-Letter-of-Intent-with-GMP-Manufacturing-Partner-for-Production-of-Proprietary-Psychedelic-Compounds

ACCESSWIRE
23 Sep 2022

https://www.accesswire.com/716358/Core-One-Labs-Akome-Move-Psychedelic-Drug-Formulations-to-Next-Stage-of-Development-Initiating-Phase-2-Analysis-of-Therapeutic-Potential

ACCESSWIRE
16 Sep 2022

https://www.accesswire.com/viewarticle.aspx?id=714615

ACCESSWIRE
02 Sep 2022

https://www.accesswire.com/711998/Core-One-Labs-Subsidiaries-Successfully-Produce-Psilocin-Precursor-for-Production-to-Psilocybin

ACCESSWIRE
12 Aug 2022

https://www.globenewswire.com/news-release/2022/04/06/2417600/0/en/Core-One-Labs-Upgrades-to-OTCQB-Venture-Market.html

GLOBENEWSWIRE
06 Apr 2022

https://www.globenewswire.com/news-release/2022/04/02/2415161/0/en/Core-One-Labs-Akome-Receives-Positive-Results-from-Bioassay-Studies.html

GLOBENEWSWIRE
04 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty